Upload Avatar (500 x 500)
Ping Liang
Medical School
Zhejiang University
Zhejiang
Language: Chinese, English
Stem Cells
Cardiovascular Diseases
Ipsc
Cardiomyocytes
Electrophysiology
Calcium Imaging
Molecular Biology
Biochemistry
Cell Biology
Biophysics
Areas of Focus
- Stem Cells and Cardiovascular Diseases
Work Experience
- 2014.04-present - Zhejiang University - Professor
- 2011.05-2014.04 - Stanford University - Postdoctoral Fellow at Cardiovascular Institute
- 2010.09-2011.04 - Biotech Pharmaceutical Co., Ltd. - Project Manager in Medical Research and Development
Academic Background & Achievements
- 2005.09-2010.06 PhD in Neuroscience: Peking University
- 2008.01-2009.01 Visiting Scholar in Physiology and Membrane Biology: University of California, Davis
- 2000.09-2005.06 Bachelor's in Clinical Medicine: China Medical University
- Major achievements in cardiovascular disease research using patient-specific iPSC-derived cardiomyocytes
Publications
- Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes, Tang L*, Wang H*, Dai B, Wang X, Zhou D, Shen J, Guo F, Wang J, Zhou J, Wang H, Wu Q, Yao H, Gong T, Su J, Meng Z#, Niu T#, Zhang L#, Liang P#, 2020
- Patient-specific and gene-corrected induced pluripotent stem cell-derived cardiomyocytes elucidate single-cell phenotype of short QT syndrome, Guo F*, Sun Y*, Wang X, Wang H, Wang J, Gong T, Chen X, Zhang P, Su L, Fu G, Su J, Yang S, Lai R, Jiang C#, Liang P#, 2019
- Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes, Tang L, Fang Yao F, Wang H, Wang X, Shen J, Dai B, Wu H, Zhou D, Guo F, Wang J, Li T, Wang H, Gong T, Su J#, Wang L#, Liang P#, 2018
- JACC, Liang P*#, Sallam K*, Wu H*, Li Y, Itzhaki I, Garg P, Zhang Y, Vermglinchan V, Lan F, Gu M, Gong T, Zhuge Y, He C, Ebert AD, Sanchez-Freire V, Churco J, Hu S, Sharma A, Lam CK, Scheinmman MM, Bers DM, Wu JC#, 2016
- Genome editing of isogenic human induced pluripotent stem cells recapitulates Long QT phenotype for drug testing, Wang Y*, Liang P*, Lan F*, Wu H*, Lisowski L, Gu M, Hu S, Kay M, Urnov F, Shinnawi R, Gold J, Gepstein L, Wu JC, 2014
- Screening drug-induced arrhythmia events using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays, Navarrete EG*, Liang P*, Lan F*, Sanchez-Freire V, Simmons CS, Gong T, Sharma A, Burridge PW, Patlolla B, Lee AS, Beygui RE, Bers DM, Wu JC, 2013
- Drug screening using a library of human induced pluripotent stem cell derived cardiomyocytes reveals disease specific patterns of cardiotoxicity, Liang P*, Lan F*, Lee AS*, Gong T, Sanchez VF, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, Nguyen PK, Bers DM, Robbins RC, Wu JC, 2013
- Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells, Lan F*, Lee AS*, Liang P*, Sanchez VF, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, Abilez OJ, Hu S, Ebert AD, Navarrete EG, Simmons CS, Wheeler M, Pruitt B, Lewis R, Yamaguchi Y, Ashley EA, Bers DM, Robbins RC, Longaker MT, Wu JC, 2013
